DANA-FARBER CANCER INST
Targeting the cytokine circuitry of KRAS driven lung cancer
Targeting the cytokine circuitry of KRAS driven lung cancer is a funding opportunity from DANA-FARBER CANCER INST, up to 460600, closing April 30, 2031.
Apr 30, 2031
(1734d left)Overview
PROJECT SUMMARY Despite recent major advances in immunotherapy and targeted therapy for KRAS mutant lung cancer, durable responses remain rare, and the vast majority of patients succumb to advanced disease. My laboratory has pursued a unique angle to the study of this disease, centered around innate immune signaling.…